FDA Approved: * August 7, 2009 Pharm Company: *TEVA PARENTERAL Category:Cancer
Oxaliplatin, sold under the brand name Eloxatin, is a cancer medication (platinum-based antineoplastic class) used to treat colorectal cancer. Often it is used together with fluorouracil and folinic acid (leucovorin) in advanced cancer. It is given by injection into a vein.
Common side effects include numbness, feeling tired, nausea, diarrhea, and low blood cell counts. Other serious side effects in...
* May have multiple approval dates, manufacturers, or labelers. 4 Discussions
Oxaliplatin 50 mg/10ml Intravenous Powder, for Solution